Editorial: Inflammatory biomarkers in type 1 diabetes
Joanna Filipowska, Antonio Rossi · 2026
Read Editorial: Inflammatory biomarkers in type 1 diabetes by Joanna Filipowska, Antonio Rossi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13236611.txt.
Description
Joanna Filipowska and Antonio Rossi introduced in 2026 a journal collection on inflammatory signals as markers in type 1 diabetes. The disease is now viewed as a long, progressive autoimmune process that starts well before diagnosis. Traditional markers such as autoantibodies, blood sugar measures, and a hormone remnant track staging but reveal little about mechanism. Inflammation and stress inside insulin-producing cells appear central to how the disease begins and advances.
Contributions in the collection range from tiny regulatory RNAs in blood to single-cell gene profiling of immune tissue. Several small RNAs discussed act both as measurable signals and as possible treatment targets in the papers. Their levels mirror cell stress, immune activation, and disease progression in patients studied. Proteomic and other large-scale methods add further candidate markers beyond the classic panel. The editors frame these signals as a bridge between mechanism and precision care for patients.
Catalog record
| CREATOR | Joanna Filipowska, Antonio Rossi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |